5-fluorouracil skin treatment for stable, localized vitiligo
Part of Skin clinical trials.
This trial tests a medicated skin powder placed on the skin to treat vitiligo that has been stable for at least a year. It may help people with localized vitiligo by trying to bring back normal skin color without changing their care mid-study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have localized, stable vitiligo (not widespread or changing quickly)
- You are older than 10 years
- Your vitiligo patches have stayed the same for at least 1 year
- You have not used vitiligo treatment for at least 6 weeks before starting
- You can agree to join and sign consent (and stay through follow-up)
- Your vitiligo is not on mucous membranes (like inside the mouth or genitals)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This trial tests whether adding a type of light therapy (narrow-band UVB) to a daily pill called ritlecitinib works better than the pill alone for treating vitiligo. It may help if you have non-segmental vitiligo covering a moderate amount of skin.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
This study tests whether microneedling (tiny needles that prick the skin) combined with a chemotherapy cream (5-fluorouracil) works better than a strong steroid cream for treating vitiligo patches on a small area of the body. It's for people with limited vitiligo (covering no more than 10% of their body) who have not used other vitiligo treatments.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.